Research

2018-2019 Milestones

 

  • ICML International Conference of Malignant Lymphoma (Switzerland):
    • Kartik Anand M.D.: Comprehensive report of anti-CD19 chimeric antigen receptor T-cells (CAR-T) associated Non Relapse Mortality (CART-NRM) from FAERS
  • ASCO 2019
    • Emre Koca M.D.: Phase II Trial Of Neoadjuvant TAK-228 Plus Tamoxifen In Patients With (ER)-Positive, HER2-Negative Breast Cancer. MERIT AWARD
    • Kartik Anand M.D.: Comprehensive report of anti-CD19 chimeric antigen receptor T cells (CAR-T) associated non-relapse mortality (CART-NRM) from FAERS. MERIT AWARD
    • Kartik Anand M.D. Neoadjuvant Phase II study of Everolimus plus Cisplatin in TNBC patients with Residual Disease
  • ASCO-SITC (Society of Immunotherapy of Cancer) 2019
    • Kartik Anand M.D.: T-cell lymphoma secondary to CPI use for other malignancies. MERIT AWARD
  • Houston Methodist Cancer Symposium 2018
    • Sarah Creamer M.D.: Best clinical Trial Poster Award
  • Texas ASCO 2018
    • Emre Koca M.D.: Association of PRAME expression with clinical features in uveal melanoma ($1000 Award)
  • ICML International Conference of Malignant Lymphoma (Switzerland):XXXX
    • Kartik: Comprehensive report of anti-CD19 chimeric antigen receptor T-cells (CAR-T) associated Non Relapse Mortality (CART-NRM) from FAERS
  • ASCO 2019
    • EMRE: Open Label, Phase II Trial Of Neoadjuvant TAK-228 Plus Tamoxifen In Patients With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor Type 2 (HER2)-Negative Breast Cancer. MERIT AWARD
    • Kartik: Comprehensive report of anti-CD19 chimeric antigen receptor T cells (CAR-T) associated non-relapse mortality (CART-NRM) from FAERS.  MERIT AWARD
    • Kartik: Neoadjuvant Phase II study of Everolimus plus Cisplatin in Triple Negative Breast Cancer (TNBC) patients with Residual Disease
  • ASCO-SITC 2019
    • Kartik: T-cell lymphoma secondary to CPI use for other malignancies. MERIT AWARD
  • Texas ASCO 2019
    • Emre Koca, $1,000 Merit Award : Anett study of neoadjuvant mtor inhibitor with tamoxifen in estrogen receptor positive breast cancer patients.
    • Usman Khan, $1,000 Merit Award : Comparison of efficacy and side effects of weekly vs. dose dense Paclitaxel in breast cancer: A meta-analysis
    • Akshjot Puri, $500 Merit Award : An association with CD 30 positive lymphomas.
    • Cesar Gentille, $500 Merit Award : Use of Radiation Therapy in Primary Mediastinal Large B-Cell Lymphoma (PMLBCL) Treated With DA-R-EPOCH.

 

 

2019 ASCO Vail Recipients

 

  • Emre Koca M.D. Phase I study of autologous T lymphocytes expressing GD2-specific chimeric antigen treatment of patients with pre-treated metastatic uveal melanoma patients.
  • Akshjot Puri M.D. Neurocognitive and Neuroimaging Assessments in Investigating the Mechanism of Cancer-Related Cognitive Impairment in Breast Cancer

 

 

2019 Publications To Date

 

  1. Schefler A, Koca E, Bernicker E, Correa Z. Relationship between clinical features, GEP class and PRAME expression in uveal melanoma.  Graefe’s Archive for clinical and experimental opthomology. 2019; 1-5.
  2. Anand K, Kumar P, Pingali SR et al. Acute myeloid leukemia with eosinophilia after cyclin-dependent kinases 4/6 inhibitor treatment due to underlying clonal hematopoiesis of indeerminate potential. Am J Hematol 2019; 94: E82-E85.
  3. Anand K, Niravath P. Acupuncture and Vitamin D for the Management of Aromatase Inhibitor-Induced Arthralgia. Curr Oncol Rep 2019; 21: 51.
  4. Anand K, Ibrahim I. Four Limb Ischemia: A Severe Case of Heparin Induced Thrombocytopenia. Indian J Hematol Blood Transfus 2019; 35: 397-398.
  5. Burns E, Anand K, Acosta G et al. Autosplenectomy in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH). Case Rep Hematol 2019; 2019: 3146965.
  6. Wallis CJ, Satkunasivam R, Butaney M, Khan UA, Goldberg HA..Klaassen et al. Association between smoking and survival benefit of immunotherapy in advanced malignancies: A systemic review and meta-analysis. American Journal of Cliniacl Oncology 2019 September; 42(9): 711-716
  7. Patel, TA, Ensor JE, Creamer SL, Boone T..Chang JC. A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2 positive breast cancer (TEAL study). Breast cancer research 2019 Sept 2; 21(1):100
  8. Kasparian S, Anand K, Burns E, Chung B, Pingali SRK. Macrophage Activation Syndrome Secondary to Underlying Sarcoidosis. 2019 Jun 18; 11(6)
  9. Anand K, Roszik J, Hall C…Patel S. Pilot Study of Circulating Tumor cells in Early Stage and Metastatic Uveal Melanoma. Cancers (Basel). 2019 Jun 20; 11(6)
  10. Anand K, Pingali SR, Trachtenberg B, Iyer SP. Complete Response to R-EPOCH in Primary Cardiac Lymphoma. Case R Hematology 2019 April 10.
  11. Anand, K, Ibrahim I. Four Lim Ischemia: A severe case of Heparin Induced Thrombocytopenia.  Indian J Hematology Blood Transfusion 2019 April
Live Chat Available